[HTML] nature.comFull View

[HTML][HTML] Targeting macrophage TFEB-14-3-3 epsilon Interface by naringenin inhibits abdominal aortic aneurysm

Y Jia, L Zhang, Z Liu, C Mao, Z Ma, W Li, F Yu, Y Wang… - Cell Discovery, 2022 - nature.com
Abdominal aortic aneurysm (AAA) is a lethal cardiovascular disease, and there is no proven
drug treatment for this condition. In this study, by using the Connectivity Map (CMap) …
被引用次数：30 相关文章

Targeting macrophage TFEB-14-3-3 epsilon Interface by naringenin inhibits abdominal aortic aneurysm

J Yiting, L Zhang, L Ziyi, M Chenfeng, M Zihan… - Cell …, 2022 - search.proquest.com
Abdominal aortic aneurysm (AAA) is a lethal cardiovascular disease, and there is no proven
drug treatment for this condition. In this study, by using the Connectivity Map (CMap) …

Targeting macrophage TFEB-14-3-3 epsilon Interface by naringenin inhibits abdominal aortic aneurysm.

Y Jia, L Zhang, Z Liu, C Mao, Z Ma, W Li, F Yu… - Cell …, 2022 - search.ebscohost.com
Abdominal aortic aneurysm (AAA) is a lethal cardiovascular disease, and there is no proven
drug treatment for this condition. In this study, by using the Connectivity Map (CMap) …

Targeting macrophage TFEB-14-3-3 epsilon Interface by naringenin inhibits abdominal aortic aneurysm

Y Jia, L Zhang, Z Liu, C Mao, Z Ma, W Li… - Cell …, 2022 - pubmed.ncbi.nlm.nih.gov
Abdominal aortic aneurysm (AAA) is a lethal cardiovascular disease, and there is no proven
drug treatment for this condition. In this study, by using the Connectivity Map (CMap) …

Targeting macrophage TFEB-14-3-3 epsilon Interface by naringenin inhibits abdominal aortic aneurysm.

Y Jia, L Zhang, Z Liu, C Mao, Z Ma, W Li, F Yu… - Cell …, 2022 - europepmc.org
Abdominal aortic aneurysm (AAA) is a lethal cardiovascular disease, and there is no proven
drug treatment for this condition. In this study, by using the Connectivity Map (CMap) …